Real-Time Label-Free Targeting Assessment and in VitroCharacterization of Curcumin-Loaded Poly-lactic-co-glycolic Acid Nanoparticles for Oral Colon Targeting

摘要

The exploitation of curcumin for oral disease treatment is limited by its low solubility, poor bioavailability, and low stability. Surface-functionalized poly-lactic-co-glycolic acid (PLGA) nanoparticles (NPs) have shown promising results to ameliorate selective delivery of drugs to the gastro-intestinal tract. In this study, curcumin-loaded PLGA NPs (C-PLGA NPs) of about 200 nm were surface-coated with chitosan (CS) for gastro-intestinal mucosa adhesion, wheat germ agglutinin (WGA) for colon targeting or GE11 peptide for tumor colon targeting. Spectrometric and zeta potential analyses confirmed the successful functionalization of the C-PLGA NPs. Real-time label-free assessment of the cell membrane-NP interactions and NP cell uptake were performed by quartz crystal microbalance coupled with supported lipid bilayers and by surface plasmon resonance coupled with living cells. The study showed that CS-coated C-PLGA NPs interact with cells by the electrostatic mechanism, while both WGA- and GE11-coated C-PLGA NPs interact and are taken up by cells by specific active mechanisms. In vitro celluptake studies corroborated the real-time label-free assessment byyielding a curcumin cell uptake of 7.3 ± 0.3, 13.5 ± 1.0,27.3 ± 4.9, and 26.0 ± 1.3 μg per 10⁴ HT-29cells for noncoated, CS-, WGA-, and GE11-coated C-PLGA NPs, respectively.Finally, preliminary in vivo studies showed that the WGA-coated C-PLGANPs efficiently accumulate in the colon after oral administrationto healthy Balb/c mice. In summary, the WGA- and GE11-coated C-PLGANPs displayed high potential for application as active targeted carriersfor anticancer drug delivery to the colon.